DUBLIN – (COMMERCIAL THREAD)–The “Global AI in Healthcare Market (2021-2026) by Sections, Diagnosis, End User, Geography, Competitive Analysis and Impact of COVID-19 with Ansoff Analysis” the report was added to ResearchAndMarkets.com offer.

The global healthcare AI market size is projected to grow from $ 6.1 billion in 2021 to reach $ 39.5 billion by 2026; it is expected to grow at a CAGR of 45.3%.

The growing volume of healthcare data and the increasing complexity of data sets are driving the need for AI, the growing need to reduce high healthcare costs, improving computing power and lowering hardware costs, the The growing number of partnerships and intersectoral collaborations and the growing imbalance between health workers and patients are driving the need for improvised health services.

Another major factor currently fueling the growth of the market is the adoption of this technology by several pharmaceutical and biotech companies around the world to accelerate vaccine or drug development processes for COVID-19. Artificial intelligence in healthcare is one of the most important scientific advances in medicine to date. The participation of several start-ups in the development of imaging and diagnostic solutions based on AI is a key factor contributing to the growth of the sector.

Recent developments

1. In March 2020, IBM Watson Health and EBSCO Information Services partnered to provide access to evidence-based information on drugs and diseases that can help clinicians and individuals cope with infectious diseases, including COVID-19 .

2. In July 2019, IBM acquired RedHat. Red Hat’s open hybrid cloud technologies are now combined with IBM’s innovation and industry expertise. IBM and Red Hat will accelerate innovation by delivering a next-generation hybrid multi-cloud platform. Based on open source technologies, such as Linux and Kubernetes, the platform will enable enterprises to securely deploy, run and manage data and applications on premises and across multiple private and public clouds.

June 3, 2020: GE Healthcare announced a collaboration with Lunit, a South Korean startup. In collaboration with Lunit, GE has launched an artificial intelligence-based chest x-ray analysis suite. The suite was designed to spot and highlight eight common conditions, using algorithms built by Lunit.

4. Jul-2020: AliveCor introduced KardiaCare, a digital health subscription service. The service provides members with the control and convenience of home heart health management. This new service provides proprietary digital tools to make it easier for users to interpret their heart data, monitor risk factors, identify symptom triggers, and measure the impact of positive lifestyle changes in the patient’s body. part of a long-term cardiac care program.

Why buy this report?

  • The report offers a comprehensive assessment of the global artificial intelligence in diagnostics market.

  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The main research is carried out through interviews, surveys and observations of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter’s 5 Force Model and Ansoff Matrix. The impact of Covid-19 on the market is also presented in the report.

  • The report also contains competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.

Market dynamics

Conductors

  • Influx of large and complex health data sets

  • Growing need to reduce healthcare costs

  • Improved computing power and lower hardware costs

  • Growing number of cross-sector partnerships and collaborations

  • Growing need for improvised health services due to the imbalance between health workers and patients

Constraints

  • Reluctance of physicians to adopt AI-based technologies

  • Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software

Opportunities

  • Growing Potential of AI-Based Tools for Elderly Care

  • Increased focus on developing human-responsive AI systems

  • Growing Potential of AI Technology in Genomics, Drug Discovery, Imaging and Diagnostics to Fight COVID-19

Challenges

  • Lack of cleared health data

  • Concerns about data privacy

  • Lack of interoperability between AI solutions offered by different vendors

Companies mentioned

  • NVIDIA Corporation (NVIDIA)

  • Intel Corporation (Intel)

  • IBM Corporation (IBM)

  • Google LLC (Google)

  • Microsoft Corporation (Microsoft)

  • General Electric X-ray Corporation (GE Healthcare)

  • Siemens Healthineers AG (Siemens Healthineers)

  • Medtronic Plc (Medtronic)

  • Micron Technologies

  • Amazon Web Services, Inc (AWS)

  • Johnson & johnson

  • Koninklijke Philips NV

  • General Vision Services (GVS)

  • Cloudmex inc. (Cloudmex)

  • Oncora Medical, Inc

  • Anju Life Sciences Software

  • CareSkore, Inc

  • Linguamics (United Kingdom),

  • Enlitic, Inc.

  • Lunit inc.

  • CureMetrix Inc.

  • Qure.ai Technologies Private Limited

  • Context Vision Operations

  • Legend Health

  • Papillon Network Inc.

  • Imagia Cybernetics Inc.

  • Precision Health Intelligence, LLC.

  • Cota Health

  • FDNA, Inc.

  • Recursion Pharmaceuticals, Inc.

  • Atomwise, Inc.

  • Deep Genomics Inc.

  • Pharmaceutical Cloud

  • Welltok, Inc.

  • Vitagene, Inc.

  • Lucina Health, Inc.

  • Next IT Corp.

  • Babylon Health

  • MDLIVE Inc.

  • Magnea

  • Physiq, Inc.

  • CyrcadieHealth

  • Caresyntaxe Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/3b8arl



Source link